KPC Pharmaceuticals, Inc. (600422.SS) SHH

Currency In CNY

AD

Valuation

Market Cap9.55B
Enterprise Value10.43B
P/E Ratio-28.84
PEG Ratio0.22
Price/Sales Ratio1.26
Price/Book Ratio1.26
Enterprise/Revenue1.51
Enterprise/EBITDA-97.37

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.04
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue6.58B
Revenue/Share6.43
Gross Profit2.53B
EBITDA638.22M
Net Income349.94M
Diluted EPS0.46

Balance Sheet

Total Cash1.71B
Total Cash/Share2.26
Total Debt2.09B
Total Debt/Equity0.43
Current Ratio1.95
Book Value Per Share8.5

Price History

52-Week Change-42.07
52-Week High14.46
52-Week Low7.45
Moving Average 50 Days8.62
Moving Average 200 Days10.21

Statistics

Average Volume10.19M
Shares Outstanding756.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield2.22
Payout Ratio-1.3
Last Split Factor2:1
Last Split DateMay 09, 2016
AD